Denali Therapeutics DNLI
NASDAQ DNLI
$19.73 -0.12 (-0.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Denali Therapeutics (DNLI) Return on Equity [ROE] (2018 - 2026)

Updated

Denali Therapeutics (DNLI) posted Return on Equity [ROE] of -57.71% for Q3 2026, down 6.65 percentage points from -51.06% a year earlier but up 0.35 percentage points from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Denali Therapeutics' Return on Equity [ROE] came in at -45.69%, down 8.29 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of -54.90 percentage points (FY2020 to FY2025).
  • In prior years, Denali Therapeutics' Return on Equity [ROE] was -37.40% in FY2024 (-23.39 pp), -14.01% in FY2023 (+18.51 pp), -32.52% in FY2022 (-5.02 pp) and -27.51% in FY2021 (-36.71 pp).
  • Quarterly Return on Equity [ROE] has run from a low of -58.07% in Q2 2026 to a high of -10.80% in Q3 2023 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last ten quarters, with an average year-over-year change of -16.91 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2024, with a gain of 25.85 percentage points; the weakest was Q3 2022, with a drop of 38.67 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -58.07% (Q2 2026), -52.37% (Q1 2026) and -52.83% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Denali Therapeutics 3.18 Bn 98.89 Mn 17.59 Mn -58.07%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -58.07%
Jun 30, 2026 -58.41%
Mar 31, 2026 -52.66%
Dec 31, 2025 -52.98%
Sep 30, 2025 -51.52%
Jun 30, 2025 -44.23%
Mar 31, 2025 -38.31%
Dec 31, 2024 -33.07%
Sep 30, 2024 -8.77%
Jun 30, 2024 -8.32%
Mar 31, 2024 13.32%
Dec 31, 2023 15.25%
Sep 30, 2023 -9.92%
Jun 30, 2023 -11.02%
Mar 31, 2023 -36.22%
Dec 31, 2022 -35.64%
Sep 30, 2022 -37.02%
Jun 30, 2022 -32.82%
Mar 31, 2022 -31.36%
Dec 31, 2021 -29.66%
API Access

Denali Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DNLI&period=max&api_key=YOUR_API_KEY